IS4679A - Bensóþíasólonafleiður - Google Patents

Bensóþíasólonafleiður

Info

Publication number
IS4679A
IS4679A IS4679A IS4679A IS4679A IS 4679 A IS4679 A IS 4679A IS 4679 A IS4679 A IS 4679A IS 4679 A IS4679 A IS 4679A IS 4679 A IS4679 A IS 4679A
Authority
IS
Iceland
Prior art keywords
bensóþíasólonafleiður
Prior art date
Application number
IS4679A
Other languages
English (en)
Inventor
Victor Bonnert Roger
Charles Brown Roger
Alan Cage Peter
Ince Francis
Pairaudeau Garry
Original Assignee
Astrazenenca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9518952.8A external-priority patent/GB9518952D0/en
Priority claimed from GBGB9614346.6A external-priority patent/GB9614346D0/en
Application filed by Astrazenenca Ab filed Critical Astrazenenca Ab
Publication of IS4679A publication Critical patent/IS4679A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C311/04—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IS4679A 1995-09-15 1998-03-04 Bensóþíasólonafleiður IS4679A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9518952.8A GB9518952D0 (en) 1995-09-15 1995-09-15 Compounds
GBGB9614346.6A GB9614346D0 (en) 1996-07-10 1996-07-10 Benzothiazolone derivatives
PCT/GB1996/002247 WO1997010227A1 (en) 1995-09-15 1996-09-12 Benzothiazolone derivatives

Publications (1)

Publication Number Publication Date
IS4679A true IS4679A (is) 1998-03-04

Family

ID=26307771

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4679A IS4679A (is) 1995-09-15 1998-03-04 Bensóþíasólonafleiður

Country Status (28)

Country Link
US (5) US5846989A (is)
EP (1) EP0850232B1 (is)
JP (1) JP3213327B2 (is)
KR (1) KR19990044674A (is)
CN (2) CN1073098C (is)
AR (1) AR004512A1 (is)
AT (1) ATE190610T1 (is)
AU (1) AU706094B2 (is)
BR (1) BR9610316A (is)
CA (1) CA2231003A1 (is)
CY (1) CY2227B1 (is)
CZ (1) CZ74098A3 (is)
DE (1) DE69607183T2 (is)
EE (1) EE03395B1 (is)
ES (1) ES2146901T3 (is)
GR (1) GR3033681T3 (is)
HU (1) HUP9802393A3 (is)
IL (4) IL141956A0 (is)
IS (1) IS4679A (is)
MY (1) MY113518A (is)
NO (1) NO310721B1 (is)
NZ (4) NZ318007A (is)
PL (1) PL325517A1 (is)
PT (1) PT850232E (is)
SK (1) SK282394B6 (is)
TR (1) TR199800457T2 (is)
TW (1) TW356468B (is)
WO (1) WO1997010227A1 (is)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2238770T5 (es) * 1997-10-17 2012-01-17 Ark Therapeutics Limited Utilización de inhibidores del sistema renina-angiotensina para el tratamiento de la hipoxia o de la disminución de la función metabólica.
SE0004750D0 (sv) * 2000-12-19 2000-12-19 Astrazeneca Ab Novel formulation
AR040962A1 (es) * 2002-08-09 2005-04-27 Novartis Ag Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
GB0218629D0 (en) * 2002-08-09 2002-09-18 Novartis Ag Organic compounds
ES2329586T3 (es) * 2003-11-21 2009-11-27 Theravance, Inc. Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino.
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
UA94235C2 (en) * 2005-08-09 2011-04-26 Астразенека Аб Novel benzothiazolone derivatives
TW200738658A (en) 2005-08-09 2007-10-16 Astrazeneca Ab Novel compounds
RU2415136C2 (ru) * 2005-08-09 2011-03-27 Астразенека Аб Новые производные бензотиазолона
TW200740781A (en) * 2005-08-29 2007-11-01 Astrazeneca Ab Novel compounds
TW200745067A (en) 2006-03-14 2007-12-16 Astrazeneca Ab Novel compounds
US20120142646A1 (en) * 2006-12-20 2012-06-07 Lilian Alcaraz Novel Compounds 621
TW200833670A (en) * 2006-12-20 2008-08-16 Astrazeneca Ab Novel compounds 569
GB0702458D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab Salts 668
JP2011524896A (ja) 2008-06-18 2011-09-08 アストラゼネカ・アクチエボラーグ 呼吸器障害の処置用のベータ2−アドレナリン受容体アゴニストとして作用するベンズオキサジノン誘導体
WO2009154562A1 (en) * 2008-06-20 2009-12-23 Astrazeneca Ab Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314944A (en) * 1980-08-22 1982-02-09 Smithkline Corporation 4-Aminoalkyl-7-hydroxy-2(3H)-indolones
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8426200D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4554284A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation 7-(2-Aminoethyl)-1,3-benzthia- or oxa-zol-2(3H)-ones
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
EP0180994A3 (en) * 1984-11-08 1987-09-23 Syntex (U.S.A.) Inc. Antihypertensive dialkyl aminoethylaniline derivatives
DE3728695A1 (de) * 1987-08-25 1989-03-09 Schering Ag Neue benzimidazol-derivate
GB9024208D0 (en) * 1990-11-07 1990-12-19 Salutar Inc Compounds
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
GB9211172D0 (en) * 1992-05-27 1992-07-08 Fisons Plc Compounds

Also Published As

Publication number Publication date
AU6937196A (en) 1997-04-01
IL141954A0 (en) 2002-03-10
IL141955A0 (en) 2002-03-10
ES2146901T3 (es) 2000-08-16
US5973167A (en) 1999-10-26
SK29598A3 (en) 1999-01-11
EP0850232B1 (en) 2000-03-15
MX9801963A (es) 1998-08-30
CY2227B1 (en) 2003-04-18
HUP9802393A3 (en) 2000-01-28
NO981104L (no) 1998-05-14
US6008365A (en) 1999-12-28
NZ332397A (en) 1999-02-25
CN1356323A (zh) 2002-07-03
NZ332396A (en) 1999-02-25
AU706094B2 (en) 1999-06-10
NO981104D0 (no) 1998-03-12
GR3033681T3 (en) 2000-10-31
IL123639A (en) 2002-04-21
US5977384A (en) 1999-11-02
TR199800457T2 (xx) 1998-07-21
DE69607183T2 (de) 2000-11-23
NO310721B1 (no) 2001-08-20
EE03395B1 (et) 2001-04-16
PT850232E (pt) 2000-08-31
CA2231003A1 (en) 1997-03-20
AR004512A1 (es) 1998-12-16
DE69607183D1 (de) 2000-04-20
NZ332395A (en) 1999-02-25
BR9610316A (pt) 1999-07-06
ATE190610T1 (de) 2000-04-15
MY113518A (en) 2002-03-30
EE9800069A (et) 1998-10-15
SK282394B6 (sk) 2002-01-07
NZ318007A (en) 1999-07-29
IL123639A0 (en) 1998-10-30
US6080869A (en) 2000-06-27
JPH11512422A (ja) 1999-10-26
WO1997010227A1 (en) 1997-03-20
EP0850232A1 (en) 1998-07-01
HUP9802393A2 (hu) 1999-04-28
US5846989A (en) 1998-12-08
IL141956A0 (en) 2002-03-10
CN1202163A (zh) 1998-12-16
KR19990044674A (ko) 1999-06-25
TW356468B (en) 1999-04-21
HK1008781A1 (en) 1999-05-21
CN1073098C (zh) 2001-10-17
CZ74098A3 (cs) 1998-08-12
JP3213327B2 (ja) 2001-10-02
PL325517A1 (en) 1998-08-03

Similar Documents

Publication Publication Date Title
DE59608860D1 (de) Bogenrotationsdruckmaschine
BR9609171A (pt) Fenilpiridazinonas
DE69524382D1 (de) Spiralverdrängermaschine
BR9609324A (pt) Macrolidas
ATA135896A (de) Skibob
DE69605312D1 (de) Rettungsflösse
NO981104L (no) Benzotiazolonderivater
DE59606332D1 (de) Benzisothiazolyl-substituierte Aminomethylchromane
BR9611619A (pt) Ciclopeptolídeos
BR9609803A (pt) Polihidroxialquilamidobetaínas
DE69528289D1 (de) Rasentraktor
DE59610938D1 (de) Plattenbanddosierer
BR9503866A (pt) Autolabor
DE59607421D1 (de) Giesspfannenschieber
FI2150U1 (fi) Serieblankett
BR7501858U (pt) Tellelight
BR9500744A (pt) Tapafugeo
BR9501962A (pt) Lotofone
BR7500192U (pt) Parasitofiltro
BR7501828U (pt) Multicopo
BR7502025U (pt) Kantil
BR9501801A (pt) Taxialerta
BR7501437U (pt) Leiteira
BR9502885A (pt) Casarreal
BR9502272A (pt) Livro-cartão